Home > News > Biophage Pharma appoints Dr. Pearl Chin to Board of Directors
October 4th, 2005
Biophage Pharma appoints Dr. Pearl Chin to Board of Directors
Biophage Pharma is pleased to announce the appointment of Dr. Pearl Chin to its Board of Directors. Dr.
Chin is the founder and managing Director of Seraphima Ventures, a private equity fund focused on Nanotechnology.
Forces of nature: Interview with microscopy innovators Gerd Binnig and Christoph Gerber August 26th, 2016
A promising route to the scalable production of highly crystalline graphene films August 26th, 2016
Graphene under pressure August 26th, 2016
New electrical energy storage material shows its power: Nanomaterial combines attributes of both batteries and supercapacitors August 25th, 2016
Dr Barbara Armbruster joins XEI Scientific as Marketing Director June 1st, 2016
Park Systems Global Expansion in AFM Market Includes Appointment of New Executives April 23rd, 2016
GLOBALFOUNDRIES Adds Alain Mutricy as Head of Product Management Group March 3rd, 2016
George Clark Named Chief Financial Officer and Associate Laboratory Director for Business Services at Brookhaven Lab February 24th, 2016